One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Joyce Nelson Biography and Net Worth

Director of Blackbaud

Joyce M. Nelson joined the Board of Directors in September 2012. From October 2011 to her retirement from full-time employment in September 2012, Ms. Nelson served as a special consultant to the in-coming President and Chief Executive Officer of the National Multiple Sclerosis Society (“NMSS”), a nonprofit organization focused on multiple sclerosis. From November 2004 to October 2011, Ms. Nelson served as President and Chief Executive Officer of NMSS. From December 1991 to November 2004, she led NMSS's national field services and fund raising departments. From June 1985 to December 1991, she led the Mid America (Greater Kansas City) chapter of NMSS. From September 1983 to June 1985, she oversaw fundraising activities for the Northern California Chapter of NMSS. Ms. Nelson was previously on the board of directors of NMSS and the Multiple Sclerosis International Federation, as well as the advisory board to the North Park University School of Non-Profit Management. Ms. Nelson holds a BA in English from North Park University. Among other experience, qualifications, attributes and skills, Ms. Nelson’s experience as a CEO, her knowledge and experience in the nonprofit industry and the senior leadership roles she played in a large nonprofit organization led to the conclusion of our Nominating and Corporate Governance Committee and of our full Board that she should serve as a director of our Company in light of our business and structure.

What is Joyce Nelson's net worth?: The estimated net worth of Joyce Nelson is at least $1.44 million as of August 24th, 2021. Ms. Nelson owns 18,333 shares of Blackbaud stock worth more than $1,435,107 as of April 26th. This net worth estimate does not reflect any other assets that Ms. Nelson may own. Learn More about Joyce Nelson's net worth.
How do I contact Joyce Nelson?: The corporate mailing address for Ms. Nelson and other Blackbaud executives is 65 FAIRCHILD STREET, CHARLESTON SC, 29492. Blackbaud can also be reached via phone at (843) 216-6200 and via email at [email protected]. Learn More on Joyce Nelson's contact information.
Has Joyce Nelson been buying or selling shares of Blackbaud?: Joyce Nelson has not been actively trading shares of Blackbaud during the last quarter. Most recently, Joyce Nelson sold 2,842 shares of the business's stock in a transaction on Tuesday, August 24th. The shares were sold at an average price of $67.57, for a transaction totalling $192,033.94. Following the completion of the sale, the director now directly owns 18,333 shares of the company's stock, valued at $1,238,760.81. Learn More on Joyce Nelson's trading history.
Who are Blackbaud's active insiders?: Blackbaud's insider roster includes David Benjamin (EVP), Anthony Boor (CFO), Andrew Brannan (VP), George Ellis (Director), Michael Gianoni (CEO), Kevin Gregoire (Insider), Andrew Leitch (Director), Kevin Mcdearis (Insider), Kevin Mooney (EVP), Sarah Nash (Director), Joyce Nelson (Director), and Jon Olson (SVP). Learn More on Blackbaud's active insiders.
Are insiders buying or selling shares of Blackbaud?: During the last year, insiders at the technology company sold shares 23 times. They sold a total of 121,057 shares worth more than $8,848,090.16. The most recent insider tranaction occured on April, 15th when CFO Anthony W Boor sold 6,900 shares worth more than $545,169.00. Insiders at Blackbaud own 1.9% of the company. Learn More about insider trades at Blackbaud.
Information on this page was last updated on 4/15/2024.

Joyce Nelson Insider Trading History at Blackbaud

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/24/2021	Sell	2,842	$67.57	$192,033.94	18,333
2/23/2021	Sell	2,000	$71.74	$143,480.00	18,012
8/7/2019	Sell	1,000	$88.62	$88,620.00	12,051
11/5/2018	Sell	1,000	$73.03	$73,030.00	15,051
5/10/2018	Sell	2,000	$101.75	$203,500.00	13,906
2/15/2017	Sell	1,000	$71.07	$71,070.00	13,254
11/15/2016	Sell	1,000	$64.69	$64,690.00	14,254
8/23/2016	Sell	600	$68.11	$40,866.00	15,254
11/11/2015	Sell	1,297	$62.00	$80,414.00	12,405

Joyce Nelson Buying and Selling Activity at Blackbaud

Blackbaud Company Overview

Blackbaud, Inc. provides cloud software solutions to nonprofits, foundations, education institutions, and healthcare organizations in the United States and internationally. The company offers fundraising and engagement solutions, such as Blackbaud Raiser's Edge NXT, Blackbaud CRM, Blackbaud eTapestry, Blackbaud Luminate Online, Blackbaud TeamRaiser, JustGiving, Blackbaud Fundraiser Performance Management, Blackbaud Guided Fundraising, and Blackbaud Altru; and financial management solutions comprising Blackbaud Financial Edge NXT, Blackbaud Tuition Management, and Blackbaud Financial Aid and Billing Management. It also provides grant and award management solutions, consisting of Blackbaud Grantmaking and Blackbaud Award Management; education solutions, such as Blackbaud Student Information System, Blackbaud Learning Management System, Blackbaud Enrollment Management System, and Blackbaud School Website System; social responsibility solutions, which includes YourCause GrantsConnect and YourCause CSRconnect, and EVERFI; Blackbaud Merchant Services and Blackbaud Purchase Cards payment services; and Blackbaud's Intelligence for Good solutions, as well as Data Health, Insights, and Performance solutions and services. The company sells its solutions and related services through its direct sales force. Blackbaud, Inc. was founded in 1981 and is headquartered in Charleston, South Carolina.

Today's Range

Now: $78.28

$75.57

$78.49

50 Day Range

MA: $72.83

$67.35

$79.18

2 Week Range

Now: $78.28

$64.32

$88.56

Volume

162,721 shs

Average Volume

278,917 shs

Market Capitalization

$4.19 billion

P/E Ratio

2,609.33

Dividend Yield

N/A

Beta

1.04

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>